Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Amyloid Fibrils

Amyloid Fibrils

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Cytoplasm

Cytoplasm

The cytoplasm consists of organelles and a framework of protein scaffolds called the cytoskeleton suspended in an aqueous solution, the cytosol. The cytosol is a rich broth of water, ions, salts, and various organic molecules.
Protein Folding and Misfolding
The cytoplasm is the location for several cellular processes, including protein synthesis and folding. The aqueous nature of the cytosol promotes protein folding such that the hydrophobic amino acid side chains are buried in the protein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Pick fold in tau filaments from human MAPT mutants.

Acta neuropathologica·2026

Same author

Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments.

eLife·2026

Same author

Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementia.

Communications biology·2026

Same author

Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Acta neuropathologica·2026

Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Search research articles

Related Experiment Video

Updated: Mar 6, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

The Synucleinopathies: Twenty Years On.

Michel Goedert¹, Ross Jakes¹, Maria Grazia Spillantini²

¹MRC Laboratory of Molecular Biology, Cambridge, UK.

Journal of Parkinson'S Disease

|March 12, 2017

Summary

This summary is machine-generated.

This review highlights the 200-year history of Parkinson's disease research, focusing on the identification of alpha-synuclein aggregation in synucleinopathies like Parkinson's disease and multiple system atrophy.

Keywords:

Alpha-synuclein Parkinson’s disease aggregate propagation dementia with Lewy bodies multiple system atrophy neurodegeneration protein aggregation

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

Related Experiment Videos

Last Updated: Mar 6, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

Area of Science:

Neuroscience
Neuropathology

Background:

Reviewing key milestones in Parkinson's disease (PD) research since James Parkinson's initial description.
Highlighting the 50th anniversary of D,L-DOPA treatment and the 20th anniversary of alpha-synuclein aggregation research.
Acknowledging the classification of multiple system atrophy (MSA) as a synucleinopathy in 1998.

Observation:

Detailed review of the identification of alpha-synuclein in pathological structures.
Specifically mentions Lewy bodies, Lewy neurites, and Papp-Lantos bodies as sites of alpha-synuclein accumulation.
Discusses subsequent research and developments following these initial discoveries.

Findings:

The identification of alpha-synuclein in Lewy bodies, Lewy neurites, and Papp-Lantos bodies.
Established alpha-synuclein aggregation as a central pathological feature in PD, dementia with Lewy bodies, and MSA.
Summarizes the evolution of understanding synucleinopathies over the past two decades.

Implications:

Enhanced understanding of the molecular pathology underlying Parkinson's disease and related synucleinopathies.
Provides a historical perspective crucial for future research directions in neurodegenerative diseases.
Informs potential therapeutic strategies targeting alpha-synuclein aggregation.